Exhibit 107.1
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Viemed Healthcare, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | ||||||||||||||||
Equity | Common shares, no par value | 457(c) and 457(h) | 7,800,000 (1)(2) | $51,792,000 (3) | $51,792,000 | 0.00014760 | $7,644.50 | ||||||||||||||||
Total Offering Amounts | $51,792,000 | $7,644.50 | |||||||||||||||||||||
Total Fee Offsets | N/A | ||||||||||||||||||||||
Net Fee Due | $7,644.50 |
(1)Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement also registers hereunder an indeterminate number of common shares issuable as a result of the anti-dilution provisions of the Registrant’s 2024 Long-Term Incentive Plan (the “Plan”).
(2)Represents 7,800,000 common shares reserved for issuance under the Plan.
(3)Pursuant to Rule 457(c) and Rule 457(h), the registration fee is calculated on the basis of the average of the high and low sale prices for the common shares on the Nasdaq Capital Market on August 7, 2024, $6.64. Pursuant to General Instruction E to Form S-8, the registration fee is calculated only with respect to additional securities registered under the Plan.
Table 2: Fee Offset Claims and Sources
Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source | |||||||||||||||||||||||||
Rule 457(p) | |||||||||||||||||||||||||||||||||||
Fee Offset Claims | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||||||||||||
Fee Offset Sources | N/A | N/A | N/A | N/A | N/A |